China is gaining a solid reputation as a pharmaceutical innovation hub, shifting from a copycat drug maker to one whose…
Read More »Hengrui
The Chinese pharmaceutical sector has significantly outperformed the broader market this year, driven by strong sales growth and a rapid…
Read More »
Jiangsu Hengrui Pharmaceuticals and Hansoh Pharmaceutical Group, two of China’s largest drug makers, are expected to report significantly improved profits,…
Read More »
Hong Kong-based venture capital firm ORI Capital plans to launch a new fund to invest in Chinese healthcare start-ups, as…
Read More »
Initial public offering (IPO) plans keep rolling in for Hong Kong’s revitalised capital market, with China’s largest pharmaceutical company launching…
Read More »
China has added dozens of new drugs to its health insurance reimbursement list, signalling support for innovative treatments while keeping…
Read More »